New preliminary research released on November 2, 2026, has linked caffeinated energy drinks and stimulant supplements to serious heart problems in young adults, finding that cardiac arrest was reported about 11 times more often in connection with the products than with products without stimulants. The analysis of more than 28,000 reports to the U.S. Food and Drug Administration found the pattern strongest among adults ages 18 to 34, a group not usually considered at high risk for heart events.
The research, led by a team at the University of Virginia School of Medicine, is set to be presented at the American Heart Association's Scientific Sessions 2026, held November 6 to 9 in Chicago. The findings are preliminary and have not yet been peer-reviewed, and the researchers stress that their analysis shows an association in reported events, not proof that the drinks caused them. Still, the numbers are striking enough that the study's authors are calling for more systematic safety monitoring of high-caffeine products sold alongside everyday soft drinks.
A $20 Billion Market Under New Scrutiny
Sales of caffeinated energy drinks have more than doubled over the past decade, reaching over $20 billion in 2024, according to the American Heart Association's release on the research. The products are marketed as everyday pick-me-ups and sold next to soda and bottled water, a placement that shapes how consumers judge their risk.
"These products are marketed as everyday pick-me-ups and sold next to soda and bottled water, so most people assume they carry no real risk," said study author Sai Samayamanthula, a fourth-year medical student at the University of Virginia School of Medicine in Charlottesville, Virginia.
Compared with brewed coffee, some energy drinks contain as much as three times more caffeine per fluid ounce, and some pre-workout supplements contain more than 12 times as much caffeine per fluid ounce, according to the release. Because the FDA regulates energy drinks and stimulant supplements as foods or dietary supplements rather than as medications, they do not go through the same premarket safety testing required for medicines.
Health care professionals have also described cases of arrhythmias, or irregular heart rhythms, and sudden cardiac death in people who had consumed these products, many of them young adults with no known heart disease risks. Research on energy drinks and other stimulant-containing supplements remains limited, but available evidence indicates that high doses of caffeine are associated with cardiovascular harm, the release said.
What the Researchers Found
The researchers analyzed 28,345 reports made to an FDA safety database about possible adverse events from 2017 to 2025, covering people ages 13 and older. Of those reports, 854 mentioned caffeine- or stimulant-containing energy drinks or dietary supplements. The researchers compared those with 27,491 reports about products without caffeine or other stimulants.
The comparison produced a consistent pattern across several serious conditions. Cardiac arrest was reported about 11 times more often in connection with caffeine- and stimulant-containing products than with products without those ingredients. Reports involving energy drinks and supplements were about 4.5 times more likely to include heart attacks and four times more likely to include ventricular arrhythmias, an abnormal rhythm in the heart's lower pumping chambers, or heart palpitations.
Similar patterns appeared for other heart conditions. Elevated heart rate was reported nearly three times more often, chest pain 2.71 times more often, and fainting about two times more often in reports involving the stimulant products. About 45 percent of the reports linking caffeine- and stimulant-containing products to cardiovascular events involved adults ages 18 to 34. Similar patterns were observed in reports involving both men and women.
The researchers grouped products by ingredient rather than by brand, so the findings point to types of products rather than any single brand. The ingredient categories included caffeine, methylxanthines such as theobromine, guarana, yerba mate and green tea or coffee extracts, and sympathomimetics such as synephrine, yohimbine, ephedra, DMAA and higenamine.
Why Young Adults Stand Out
Researchers do not fully understand why the association was so frequent among young adults, but they offered several possible explanations. The pattern may reflect how often young people consume caffeine- and stimulant-containing products, when or how they tend to consume them, or whether they have an undiagnosed heart condition.
Timing and context matter, the researchers said. People may consume these products before intense exercise or mix them with alcohol or drugs, situations that could amplify strain on the heart.
"For many healthy people, if these products are consumed occasionally, the risk is probably small," Samayamanthula said. "However, individuals who consume energy drinks or other stimulant-containing supplements regularly can quickly exceed the recommended daily limit for caffeine, so it's important for people to know that there may be a risk of cardiovascular harm with these products."
According to a 2026 American Heart Association scientific statement on caffeine and cardiovascular disease, consuming up to 400 milligrams of caffeine per day, the equivalent of up to five 8-ounce cups of regular black caffeinated coffee, is generally safe for most adults. Regular use of high-caffeine drinks and supplements can push a consumer past that limit quickly, especially when several products are combined in a single day.
What This Means
The study's central message is a call for closer attention, not a verdict. Its authors argue that the pattern in FDA reports supports more systematic safety monitoring of caffeine- and stimulant-containing products, and they urge health care professionals to ask younger patients who report palpitations, chest pain or fainting spells whether they recently or regularly consume these products.
"Our findings support the case for more systematic safety monitoring of caffeine- and stimulant-containing products," Samayamanthula said. "In addition, health care professionals should remember to ask their younger patients who have palpitations, chest pain or fainting spells if they recently or regularly consume these products."
Independent experts echoed the caution. Dr. Gregory M. Marcus, chair of the 2026 American Heart Association scientific statement on caffeine and cardiovascular disease, said the study raises concerns about very high caffeine products but does not prove they cause heart events. Marcus, who was not involved in the study, is a professor of medicine at the University of California, San Francisco School of Medicine.
"This study raises concerns that products with very high amounts of caffeine may be harmful to the cardiovascular system," Marcus said. "Although there are biological reasons why that connection could be possible, the study does not prove that caffeine products cause these events, because other factors may have influenced the results found in this analysis. More research is needed to understand whether these stimulant products are truly responsible for the reported heart-related events."
That distinction matters for consumers reading alarming headlines. The study's design only identified associations between caffeinated products and cardiac events that were voluntarily reported to the FDA. It cannot prove that the products directly caused any heart condition or event, and voluntary reporting has built-in blind spots: it is unknown how many people consumed the products without experiencing any cardiac event, and how many experienced cardiac events and never reported them.
What Happens Next
The research will be presented in full at the American Heart Association's Scientific Sessions in Chicago from November 6 to 9, where cardiologists will be able to question the methods and the strength of the signal. The findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal, and the authors themselves say more research is needed to determine whether stimulant products are truly responsible for the reported heart events.
For now, the practical guidance in the reporting is measured. Occasional consumption by healthy people probably carries a small risk, according to the study's lead author, but regular users should pay attention to total daily caffeine, especially from products that pack several times the caffeine of coffee into a single serving. Young adults who experience palpitations, chest pain or fainting after using energy drinks or pre-workout supplements should mention the products to a doctor, since clinicians may not otherwise think to ask.
The findings land in a market that keeps growing, with energy drinks now a fixture of convenience-store shelves and gym bags alike. Whether regulators, retailers or manufacturers respond with new labeling, monitoring or marketing limits will depend on what the fuller evidence shows, but the November 2 release has already put a familiar product back under the microscope.
Post a Comment